77423-14-4

Basic information

• Product Name: 4-CARBOXYLIC-ISATOIC ANHYDRIDE
• Synonyms: 2,4-DIOXO-1,4-DIHYDRO-2H-BENZO[D][1,3]OXAZINE-7-CARBOXYLIC ACID;4-CARBOXYLIC-ISATOIC ANHYDRIDE;2H-3,1-Benzoxazine-7-carboxylic acid, 1,4-dihydro-2,4-dioxo-;2,4-Dioxo-2,4-dihydro-1H-benzo[d][1,3]oxazine-7-carboxylic acid
• CAS NO: 77423-14-4
• Molecular Formula: C₉H₅NO₅
• Molecular Weight: 207.14
• Mol File: 77423-14-4.mol
• Article Data: 11

Chemical Properties

• Melting Point: 347.0 °C
• Appearance: /
• Density: 1.607g/cm³
• Refractive Index: 1.631
• Storage Temp.: 2-8°C
• PKA: 3.44±0.20(Predicted)
• CAS DataBase Reference: 4-CARBOXYLIC-ISATOIC ANHYDRIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-CARBOXYLIC-ISATOIC ANHYDRIDE(77423-14-4)
• EPA Substance Registry System: 4-CARBOXYLIC-ISATOIC ANHYDRIDE(77423-14-4)

Safety Data

• Statements: 36/37/38
• Safety Statements: 26-36/37/39
• Hazardous Substances Data: 77423-14-4(Hazardous Substances Data)

Usage

General Description

4-Carboxylic-isatoic anhydride, also known as 1H-3a,4-dihydro-4-oxo-1,4-diene-2,3-dicarboxylic anhydride, is a chemical compound with the molecular formula C8H4O5. It is a white solid with a molecular weight of 180.12 g/mol. 4-CARBOXYLIC-ISATOIC ANHYDRIDE is mainly used as an intermediate in the synthesis of pharmaceuticals, dyes, and pigments. It is also used as a building block in organic chemistry for the preparation of various organic compounds. 4-Carboxylic-isatoic anhydride has potential applications in the pharmaceutical industry due to its reactivity and ability to undergo various chemical transformations, making it a versatile and valuable chemical compound.

InChI:InChI=1/C9H5NO5/c11-7(12)4-1-2-5-6(3-4)10-9(14)15-8(5)13/h1-3H,(H,10,14)(H,11,12)

Upstream product

• 32315-10-9 bis(trichloromethyl) carbonate 
• 10312-55-7 3-aminoterephthalic acid 
• 503-38-8 trichloromethyl chloroformate 
• 5372-81-6 dimethyl aminoterephthalate 
• 75-44-5 phosgene 

Downstream Products

• 942152-81-0 3-benzyl 7-methyl 4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinoline-3,7-dicarboxylate 
• 1374779-41-5 C₁₄H₁₁ClN₂O₃ 
• 218590-81-9 1-ethyl 2-aminoterephthalate 
• 1391926-99-0 C₂₂H₁₄N₂O₉ 
• 1391926-96-7 1-phenyl 2-aminoterephthalate 
• 1374778-41-2 3-(3-chlorobenzo[b]thiophene-2-carboxamido)-4-(3-cyanophenylcarbamoyl)benzoic acid 
• 1374779-57-3 3-(3-chlorobenzo[b]thiophene-2-carboxamido)-4-(3-chlorophenylcarbamoyl)benzoic acid tert-butyl ester 
• 1374779-56-2 C₁₈H₁₉ClN₂O₃ 
• 1374778-19-4 3-(3-chlorobenzo[b]thiophene-2-carboxamido)-4-(3-chlorophenylcarbamoyl)benzoic acid 
• 1374777-73-7 3-(benzo[b]thiophene-2-carboxamido)-4-(4-chlorophenylcarbamoyl)benzoic acid 
• 1374779-55-1 3-amino-N-(3-chlorophenylcarbamoyl)benzoic acid 
• 1374779-49-3 C₁₅H₁₁N₃O₃ 
• 1261594-20-0 methyl 3-benzyl-1-methyl-5-oxo-2,3,4,5-tetrahydro-1H-benzo[d][1,3]diazepine-8-carboxylate 

Relevant articles and documents

MODIFIED PROTEINS AND PROTEIN DEGRADERS

Provided herein are compounds, pharmaceutical compositions, and methods for binding or degrading target proteins. Further provided herein are compounds having a DNA damage-binding protein 1 (DDB1) binding moiety. Some such embodiments include a linker. Some such embodiments include a target protein binding moiety. Further provided herein are ligand-DDB1 complexes. Further provided herein are in vivo modified DDB1 proteins.

METHODS AND COMPOSITIONS FOR DRUGS TO TREAT OPHTHALMIC DISEASES

The presently disclosed subject matter is directed to compositions and methods for treating CaMKK2-mediated ophthalmic diseases, including but not limited to 1) ocular surface inflammatory diseases (OSIDs), including but not limited to ocular graft versus

COMPOUNDS AND METHODS OF TREATING RNA-MEDIATED DISEASES

The present invention provides compounds, compositions thereof, and methods of using the same.